Cargando…
Negative anti-phospholipase A2 receptor antibody status at three months predicts remission in primary membranous nephropathy
BACKGROUND: The value of anti-phospholipase A2 receptor antibody (anti-PLA2R ab) monitoring at 3 months after diagnosis in membranous nephropathy (MN) remains uncertain. METHODS: We retrospectively examined the outcome on 1 August 2020 of 59 adult patients (age 54 (44, 68) years, 69% male, SCr 1.0 (...
Autores principales: | Stefan, Gabriel, Stancu, Simona, Zugravu, Adrian, Popa, Otilia, Zubidat, Dalia, Petre, Nicoleta, Mircescu, Gabriel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863379/ https://www.ncbi.nlm.nih.gov/pubmed/35172682 http://dx.doi.org/10.1080/0886022X.2022.2033265 |
Ejemplares similares
-
Histologic predictors of renal outcome in diabetic nephropathy: Beyond renal pathology society classification
por: Stefan, Gabriel, et al.
Publicado: (2019) -
Nephrotic Syndrome and Statin Therapy: An Outcome Analysis
por: Busuioc, Ruxandra, et al.
Publicado: (2023) -
Clinical Phenotypes and Predictors of Remission in Primary Membranous Nephropathy
por: Jurubiță, Roxana, et al.
Publicado: (2021) -
Anti-phospholipase A2 receptor antibody and spontaneous remission in membranous nephropathy
por: Diaz, Montserrat, et al.
Publicado: (2018) -
Subclinical cardiovascular disease markers and vitamin D deficiency in non-dialysis chronic kidney disease patients
por: Căpuşa, Cristina, et al.
Publicado: (2016)